Zobrazeno 1 - 10
of 34
pro vyhledávání: '"A. T. A. Fazekas"'
Autor:
Lombardo D, Mezghrani A, Nezha Samih, A. Aouani, Guy Fayet, Mykhaylov S, Sonia Hovsepian, T. Amphoux-Fazekas
Publikováno v:
Hormone and Metabolic Research. 31:402-405
The polar planar compound hexamethylene bisacetamide (HMBA) is an inducer of terminal differentiation which has been extensively studied in the murine erythroleukemia cells (MELC). We have tested this compound in normal porcine thyroid cells in prima
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2e01d29fd81bab2e03325be2eca91aa
https://doi.org/10.1055/s-2007-978763
https://doi.org/10.1055/s-2007-978763
Publikováno v:
Comptes Rendus de l'Académie des Sciences - Series III - Sciences de la Vie. 320:1-11
Resume Le compose hexamethylene bisacetamide (HMBA) est un agent de differenciation pour les cellules murine de leucemie erythrocytaire (MELC). Il induit comme le dimethylsulfbxyde l'engagement vers la differenciation terminale en reactivant l'expres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::412142507139fbeed7fb37dcee25fab5
https://doi.org/10.1016/s0764-4469(99)80080-8
https://doi.org/10.1016/s0764-4469(99)80080-8
Publikováno v:
Molecular and Cellular Endocrinology. 117:111-116
Hexamethylenebisacetamide (HMBA) provokes in murine erythroleukemia cells (MELC) a commitment to terminal differentiation leading to the activation of the expression of hemoglobin. HMBA has been tested also in other cells from colon cancer, melanoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f23050cb243ac691ecdedd8b81806955
https://doi.org/10.1016/0303-7207(95)03732-2
https://doi.org/10.1016/0303-7207(95)03732-2
Publikováno v:
Archives of physiology and biochemistry. 107(2)
Hexamethylenebisacetamide (HMBA) induces in murine erythroleukemia cells (MELC) the commitment to terminal differentiation leading to globin gene expression. In the thyroid, HMBA acts as a growth factor and also as a differentiating agent. In the pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f05b8a67c613bb34df8adb26bf7a9a7
https://pubmed.ncbi.nlm.nih.gov/10650339
https://pubmed.ncbi.nlm.nih.gov/10650339
Autor:
A. Aouani, Renaud Beauwens, Nezha Samih, T. Amphoux-Fazekas, Guillaume Fayet, Sonia Hovsepian
Publikováno v:
Molecular and cellular endocrinology. 141(1-2)
4,4'-Di-isothiocyanatostilbene-2,2'-disulfonic acid (DIDS), an inhibitor of several anionic channels and transporters including the band 3 protein of the red blood cell membrane was tested on iodide metabolism in cultured porcine thyroid cells. We us
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c2c88ca772217bedc26220f745234ad
https://pubmed.ncbi.nlm.nih.gov/9723894
https://pubmed.ncbi.nlm.nih.gov/9723894
Publikováno v:
Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie. 320(1)
The polar compound hexamethylenebisacetamide (HMBA) is a differentiating agent in the murine erythroleukemia cell system (MELC). It induces, like dimethylsulfoxide, the commitment to terminal differentiation leading to a recovery in the expression of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b666ee38a2089562d93bbe4df8294219
https://pubmed.ncbi.nlm.nih.gov/9099258
https://pubmed.ncbi.nlm.nih.gov/9099258
Publikováno v:
Journal of Endocrinology. 66:159-164
SUMMARY The effect of genetic difference (white v. coloured) on the cortisol content of ten different organs and tissues, including the adrenals, of white and coloured guinea-pigs of both sexes and of different ages was studied by protein-binding tec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::346bc011ad798b6fd9bce2c92aca5c53
https://doi.org/10.1677/joe.0.0660159
https://doi.org/10.1677/joe.0.0660159
Publikováno v:
Human Genetics. 32:35-41
The urinary excretion of steroids was studied in 8 parents of children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency of the simple virilizing and of the salt-losing type. Eight parents of normal children served as controls. 24-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::593321eceebe5fb92f3a1bfa2eb40495
https://doi.org/10.1007/bf00569974
https://doi.org/10.1007/bf00569974
Autor:
Andrew V. Schally, George Tolis, A. T. A. Fazekas, A. M. Comaru-Schally, A. Mehta, Fernand Labrie, D. Ackman, A. Stellos
Publikováno v:
Proceedings of the National Academy of Sciences. 79:1658-1662
Ten patients with prostatic carcinoma--six with stage C and four with stage D disease--were treated for 6 weeks to 12 months with agonistic analogues of luteinizing hormone-releasing hormone (LH-RH). [D-Trp6]LH-RH was given subcutaneously once daily
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b17e0714975c6a4e88150617d0ed2ab
https://doi.org/10.1073/pnas.79.5.1658
https://doi.org/10.1073/pnas.79.5.1658
Autor:
N. Faure, Michael Koutsilieris, S. Klioze, André Lemay, A. Yakabow, A. T. A. Fazekas, George Tolis
Publikováno v:
Journal of Steroid Biochemistry. 19:995-998
Forty-six patients with prostatic carcinoma received the gonadotropin releasing hormone agonistic analogue (GnRH-A) Buserelin at doses ranging from 0.05 to 1.5 mg subcutaneously and/or 0.4 to 1.2 mg intranasally (i.n.) daily for 12-120 weeks. An incr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ecee9488c7e5758fff9ec3106e8c87f0
https://doi.org/10.1016/0022-4731(83)90045-6
https://doi.org/10.1016/0022-4731(83)90045-6